Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase NA 3Phase 4 3Phase 3 3Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Smoking 1Lung Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Varenicline × Clear all
NCT02048917 2020-01-29

Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

University of Kentucky

Phase 1 Completed
93 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡